-- Tuesday, 11 February 2020
The potential applications of nanomaterials to nanotheranostics, i.e. concurrent diagnostics and therapy, are discussed in a review signed by Xin Yi Wong, formerly a member of the ICN2 Nanobioelectronics and Biosensors Group, and by Group Leader ICREA Prof. Arben Merkoçi. The essay has just been published in ACS Nano.
-- Monday, 10 February 2020
This liver cancer is the most common and is in need of new therapeutic approaches. A long-term collaboration between IDIBAPS and ICN2, led by Prof. Wladimiro Jiménez and Prof. ICREA Víctor F. Puntes, has demonstrated that the administration of cerium oxide nanoparticles in a rat animal model can compete with the best currently available treatments. The Research published in Hepatology shows that human tissues also absorb and retain the nanoparticles, making them a potential and promising new drug strategy.
-- Tuesday, 04 February 2020
On the occasion of the World Cancer Day, occurring on February 4 and dedicated to global awareness about cancer, we would like to highlight various research lines oriented at improving tumour diagnosis and treatment in which the ICN2 is involved.
-- Tuesday, 04 February 2020
La Vanguardia has selected the brain-computer interfaces designed by the ICN2 and IMB-CNM-CSIC, with a long list of close collaborators, among the candidates to win its prestigious award Vanguardia de la Ciencia. Help us disseminate the fight against epilepsy, migraine or brain damage with nanotechnology. The winner will be one of the 8 candidates that will be selected through popular vote.
-- Monday, 03 February 2020
As 11 February approaches, several scientific institutions are warming up in preparation for the International Day of Women and Girls in Science. That is been the case for BIST, the Barcelona Institute of Science and Technology, of which the ICN2 is a member. Last Thursday 30 January, the BIST held an act in the Barcelona Biomedical Research Park premises to prepare for the 100tífiques event.
